ETF Managers Group’s Emergent Biosolutions EBS Stock Holding History

ETF Managers Group’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$172K	Buy	16,647 +4,209	+34%	+$50.9K	0.01%	597
2022 Q4	$147K	Sell	12,438 -2,276	-15%	-$35.2K	0.01%	486
2022 Q3	$309K	Sell	14,714 -1,160	-7%	-$32.3K	0.01%	552
2022 Q2	$485K	Buy	15,874 +555	+4%	+$18.9K	0.01%	500
2022 Q1	$640K	Sell	15,319 -941	-6%	-$41.5K	0.01%	419
2021 Q4	$734K	Sell	16,260 -3,286	-17%	-$149K	0.01%	412
2021 Q3	$1.01M	Buy	19,546 +3,741	+24%	+$227K	0.02%	269
2021 Q2	$1.01M	Sell	15,805 -521	-3%	-$33.5K	0.02%	273
2021 Q1	$1.47M	Sell	16,326 -9,452	-37%	-$968K	0.03%	229
2020 Q4	$2.39M	Buy	25,778 +6,203	+32%	+$569K	0.05%	182
2020 Q3	$2.04M	Buy	19,575 +9,270	+90%	+$999K	0.06%	157
2020 Q2	$777K	Buy	+10,305	New	+$768K	0.03%	210

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

ETF Managers Group's EBS Position: Q1 2023 in Review

ETF Managers Group increased its Emergent Biosolutions (EBS) stake by 34% in Q1 2023, buying an estimated $50.9K and bringing the position to 16,647 shares worth $172K. The position accounts for 0.01% of the portfolio, ranked #597.

ETF Managers Group first reported a position in EBS in Q2 2020 and has held it in 12 quarters since. The position peaked at $2.39M in Q4 2020. 189 funds tracked by Wall St. Rank hold EBS as of Q1 2023.

ETF Managers Group held 16,647 shares of Emergent Biosolutions worth $172K as of Q1 2023.
ETF Managers Group bought 4,209 Emergent Biosolutions shares in Q1 2023, an estimated $50.9K.
Emergent Biosolutions made up 0.01% of ETF Managers Group's portfolio in Q1 2023, its #597 holding.
ETF Managers Group first reported a position in Emergent Biosolutions in Q2 2020 and has held it in 12 quarters since.
ETF Managers Group's Emergent Biosolutions position peaked at $2.39M in Q4 2020.
189 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.